Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
study well documented, meets generally accepted scientific principles, acceptable for assessment

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1977
Report date:
1977

Materials and methods

Test guideline
Qualifier:
no guideline followed
Principles of method if other than guideline:
Three groups of 5 female SD rats were exposed to 100, 215, and 464 mg/kg bw via i.p. and mortality was determined for 7 days.
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
1,1,2,3,3,6-hexamethylindan-5-yl methyl ketone
EC Number:
239-360-0
EC Name:
1,1,2,3,3,6-hexamethylindan-5-yl methyl ketone
Cas Number:
15323-35-0
Molecular formula:
C17H24O
IUPAC Name:
1,1,2,3,3,6-hexamethylindan-5-yl methyl ketone
Test material form:
solid
Specific details on test material used for the study:
- Description: Clear liquid (super saturated)

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Age at study initiation: 121 - 172 g
- Fasting period before study: overnight

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
ethanol
Details on exposure:
100 and 215 mg/kg bw: 25% in ethanol
464 mg/kg bw: undiluted
Doses:
100, 215, 464 mg/kg bw
No. of animals per sex per dose:
5
Control animals:
no
Details on study design:
- Duration of observation period following administration: 7 days
- Frequency of observations: Observations for mortality and signs of effects were made immediately after dosing at one, four, and 24 hours, and once daily thereafter
- Necropsy of survivors performed: yes
Statistics:
Mortality data was analyzed statistically, utilizing the tables of Horn H.J., Biometrics 12, 311, 1956

Results and discussion

Effect levels
Sex:
female
Dose descriptor:
LD50
Effect level:
271 mg/kg bw
Based on:
test mat.
95% CL:
>= 167 - <= 441
Mortality:
100 mg/kg bw: No mortality was observed
215 mg/kg bw: Two animals died within 1 day
464 mg/kg bw: Two animals died within 1 day. Two other animals died one day later.
Clinical signs:
100 mg/kg bw: None
215 mg/kg bw: One of the animals who died exhibited slightly depressed behavior. This animal was also stained on the body fur with urine, which indicates a lack of normal preening.
464 mg/kg bw: One animal who died was prostrate.
Gross pathology:
100 mg/kg bw: None
215 mg/kg bw: The two animals who were found dead exhibited expected effects of their stages of autolysis
464 mg/kg bw: Two animals exhibited yellow coloration in the large intestines and another exhibited a lighter coloration of the brain than would normally be expected. All other animals in the study exhibited no remarkable effects.

Applicant's summary and conclusion